Augmedix Inc
NASDAQ:AUGX
Augmedix Inc
Research & Development
Augmedix Inc
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Augmedix Inc
NASDAQ:AUGX
|
Research & Development
-$11.2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Veeva Systems Inc
NYSE:VEEV
|
Research & Development
-$629m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-37%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Research & Development
-$116.5m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
-74%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Research & Development
-$80.2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Certara Inc
NASDAQ:CERT
|
Research & Development
-$34.2m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
See Also
What is Augmedix Inc's Research & Development?
Research & Development
-11.2m
USD
Based on the financial report for Dec 31, 2023, Augmedix Inc's Research & Development amounts to -11.2m USD.
What is Augmedix Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-10%
Over the last year, the Research & Development growth was -10%. The average annual Research & Development growth rates for Augmedix Inc have been -35% over the past three years , -10% over the past five years .